Pediatrics
News
‘Sugar tax’ prevented thousands of girls becoming obese
Reductions were greatest in girls whose schools were in the most deprived areas, where children are known to consume the largest amount of sugary...
News
FDA okays Tidepool Loop app to help guide insulin delivery
Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older...
News
AD outcomes improved with lebrikizumab and topical steroids
The percentage of patients who achieved the combined endpoint was more than double for the lebrikizumab plus TCS group vs. the group on TCS alone...
News from the FDA/CDC
Children and COVID: ED visits and hospitalizations start to fall again
CDC data show that weekly cases have been declining since early December.
Commentary
Spikes out: A COVID mystery
A new study does a great job of...
News
Study spotlights clinicopathologic features, survival outcomes of pediatric melanoma
The median Breslow thickness was 2.7 mm in children and 1.0 mm in adolescents.
News
New guidelines on peds obesity call for aggressive treatment
The authors of the guidelines encourage primary care doctors to collaborate with other medical professionals to treat the comorbidities often...
News
Berdazimer gel under review at FDA for treating molluscum contagiosum
A 3.4% formulation is in development for the topical treatment of acne.
News from the FDA/CDC
Children and COVID: New cases fell as the old year ended
Emergency department visits keep increasing as the pandemic’s death toll in children nears 2,000.
News
FDA approves Wegovy (semaglutide) for obesity in teens 12 and up
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.